101 AUDITED FINANCIAL STATEMENTS 2021 NOTES TO THE FINANCIAL STATEMENTS FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2021 24 INVESTMENT IN SUBSIDIARIES Company 2021 2020 RM’000 RM’000 At cost less accumulated impairment (i) Malaysian quoted shares: Ordinary shares: At 1 January 208,590 196,190 Reversal of impairment (Note 24(d)) – 12,400 At 31 December 208,590 208,590 (ii) Malaysian unquoted shares: Ordinary shares: At 1 January 6,679,174 6,670,611 Additions 2,780 10,570 Impairment loss (Note 24(d)) – (5,500) Conversion of amount due from a subsidiary into investment in equity of the subsidiary (Note 29) 5,217 3,493 At 31 December 6,687,171 6,679,174 (iii) Foreign unquoted shares: At 1 January/31 December 9,232 9,232 (iv) RCPS/RCCPS: At 1 January 1,580,549 1,533,249 Reversal of impairment (Note 24(d)) – 47,300 At 31 December 1,580,549 1,580,549 (v) Capital contribution to subsidiaries: At 1 January/31 December 15,482 15,482 Total 8,501,024 8,493,027 Market value of Malaysian quoted shares, based on Group’s effective interest 458,906 204,356 The disclosure of market value of Malaysia quoted shares is based on Level 1 fair value computation.
RkJQdWJsaXNoZXIy NDgzMzc=